Type 2 diabetes drug cost-effective for cardiovascular and kidney benefits, finds new study Mirage Newssource Post navigation Diabetes after SARS-CoV-2 infection – The Lancet CGM use lowers hospitalizations, may reduce mortality in type 1 and type 2 diabetes – Healio